chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swollen lymph nodes under left arm; swollen left breast; redness on breast; This is a spontaneous report from a contactable consumer, the patient. An 82-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201) via an unspecified route of administration in the left arm on 15Feb2021 (at the age of 82-years-old), as a single dose for COVID-19 immunisation. Medical history included allergic to wasp bites. Concomitant medications received within two weeks of vaccination included statin (MANUFACTURER UNKNOWN), for unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL8982) via an unspecified route of administration in the left arm on 25Jan2021 at 00:00 (at the age of 82-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Feb2021, the patient experienced swollen lymph nodes under left arm, swollen left breast and also redness on breast. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swollen lymph nodes under left arm, swollen left breast and redness on breast was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
He developed a cough and grunting - seen with fever and irritability. Diagnosed as meningitis. Treated empirically with antibiotics. All cultures were negative. Discharged home.
Mild/moderate localize swelling with some erythema at injection site. No pain or signs of infection noted. No other s/s of allergic rx. Recommend pt tried cool compress and take benadryl x 1 day along with naproxen for edema.
Localized itching, redness, swelling at injection site followed by hives all over body, wheezing, sneezing, swollen eyes, vomiting.
Patient reports S.O.B, tight throat, nausea, diarrhea approximately 3 hrs after vaccination was treated with BENADRYL.
On the afternoon of 4/29/2021 at 2pm, patient came to the pharmacy after receiving her second Pfizer-Biontech COVID-19 vaccine on 4/27/2021 at 1pm.  She spoke with pharmacist regarding side effects.  She stated that on 4/27/2021 after receiving her vaccine, she woke up in the evening around 8pm feeling soreness in her arm and tingling that radiated from the injection site in the left deltoid muscle to the tips of her fingers.  She told the pharmacist that on the following day 4/28/2021 at around 1pm she took some Tylenol for the pain. She noticed at that point that her arm and fingers were swollen, numb, and that she could not fully close her hand.  When she appeared at the pharmacy on 4/29/2021, she stated that her ability to move her hand had returned, but that the swelling and numbness were still the same.  Pharmacist observed that her arm around the injection site was warm and swollen.  She advised the patient to contact her medical provider for further evaluation and in the meantime continue to use Tylenol (the patient could not use anti-inflammatory medications due to a medical condition) and apply cold compresses to the arm.  She also requested the patient to contact the pharmacy for any further questions and to provide an update the following day on 4/30/2021.  On 4/30/2021, pharmacist reached out to the patient at 10am to follow up. The patient stated that swelling and numbness in the hand had decreased, but the tingling sensation was still present.  She is planning on following up with a medical provider today.
Swelling and red bicep away from the shot. Arm is surfer painful as well.
Fever, chills, shaking teeth chattered; body aches ; sweating; nausea
gave a 10 year old the dose for over 12 years 30mcg not 10mcg
This case was reported by a nurse via sales rep and described the occurrence of erythema in a 61-year-old female patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On an unknown date, 1 day after receiving SHINGRIX, the patient experienced erythema, swelling, pain and malaise. On an unknown date, the outcome of the erythema, swelling, pain and malaise were recovered/resolved. The reporter considered the erythema, swelling, pain and malaise to be related to SHINGRIX. Additional details were provided as follows: The case was reported by licensed practical nurse (LPN). The age at vaccination was not reported, but it could be either 61 or 62 year old. The reporter had the limited information.
GENERAL FLU LIKE SYMPTOMS X ABOUT 72-96 HOURS, THEN FLAT, ERYTHEMATOUS RASH ON BACK OF ARM, BELOW THE INJECTION SITE, LIGHT BRUISING AROUND INJECTION SITE. RASH HAS PERSISTED X 5 DAYS AFTER INJECTION
Swollen/tender to the touch face. Specifically under the eyes, cheeks, and chin. It hurts to smile. Started at 4 am 1.5 days after 2nd dose. Also a light bloody nose at 8 am less than 48 hrs after shot.
I started experiencing a feeling of pressure in my neck. I already have an existing thyroid condition so I went to see my doctor so that they could take a look. They did a thyroid ultrasound, and it showed a nodule on my thyroid. I was referred to an Ear, Nose, and Throat doctor. He did a procedure to check my vocal cords. He diagnosed me with gastro reflux disease. I was prescribed Pepcid 40mg 1xday. The medicine is helping, and the doctors are going to monitor it yearly.
Atypical Headache, Hemiplegia-L.U.E and L.L.E. Altered Sensorium Hyperreflexia.
Patient stated after the fact that she had a severe reaction to the Moderna shot, did not get the 2nd shot and her Dr. instructed her to get a different vaccination to see if that one would work. This does not follow the guidelines and the shot was given by mistake.  No reaction occurred while in the store with the new vaccination.
Initial consumer report received on 08 Aug 2010: On an unknown date, this patient was vaccinated with only the liquid portion meningitis vaccine, taken as MENVEO (batch number: unknown), unknown dose without being reconstituted. No adverse events were noted following this medication error.
Red, tender, hot spot on arm where vaccine administered. Rash appeared 1 day after given and still present 48 hours after.
Patient had severe arm pain, chest pain, palpitations, and overall unwell. Patient went to hospital that evening and med team ruled out any heart problem/concerns. Patient went home and was told to rest well. 11/26/22: Patient stated feeling better at this time, but not 100% yet.
EXTREME SORENESS, graduating to excruciating pain in arm, 101.7 degrees temp. intense pain 4 days, moderating to lesser degree for 6 more days...used ice, Tylenol, Voltaren gel.
Coughing; wheezing; difficulty breathing; Body ache; tired; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing), WHEEZING (wheezing), DYSPNOEA (difficulty breathing), MYALGIA (Body ache) and FATIGUE (tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     Concurrent medical conditions included Glaucoma (medicine for one eye).    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced COUGH (Coughing), WHEEZING (wheezing), DYSPNOEA (difficulty breathing), MYALGIA (Body ache) and FATIGUE (tired). At the time of the report, COUGH (Coughing), WHEEZING (wheezing), DYSPNOEA (difficulty breathing), MYALGIA (Body ache) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication includes inhaler, Flonase.
Initial information received from a healthcare professional on 19 July 2013. A 07-month-old female patient had received a dose of DAPTACEL (batch number, dose number and route of administration were not reported) on the leg on an unspecified date. The patient's old brother had severe food allergies. The patient's medical history and concomitant medications were not reported. On an unspecified date, after vaccination, the patient presented injection site hard swelling. Complementary investigations and corrective treatments were not reported. The hard swelling took a week to go away and on an unspecified date, the patient had recovered from the event. Documents held by sender: none. Follow-up information received from a health care professional on 09 September 2013. It was reported that the component of Dtap Stainer-Scholte liquid medium source was under investigation as children were highly allergic to nuts, eggs, cow's milk, gluten and other foods. The patient also had symptomatology of eczema as her brother had since an unspecified date. This case is linked to the case 2013-09652 (brother case, received from same reporter).
1-12-2021 at 11 pm Softball size soft and red swelling at site evening of vaccine.  Vaccine received at 1 pm that day 1-16-2021 Itching at site started.  Swelling and redness remain 1-19-2021 A second redness swelling at same arm but higher and more medial under armpit area.  Painful, swollen lymph nodes at arm pit.
Numbness in face tht stopped after a hour. Continuous numbness in hand all on same side of body as the shot was given
Started with sore throat, fever, chills, headache. Then went into stuffiness, congestion, minor cough. Then started to settle into my chest on day 10. I could really feel it in my chest at that point, so I went to the ER and thought it was pneumonia, but it was actually bronchitis. Still experiencing chest tightness after a couple weeks currently. Also had a loss of taste and smell during the COVID infection.
Muscle at Injection site continue to experience sourness till this day; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 11May2021 11:45 (Batch/Lot number: unknown) at the age of 32 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: EFEXOR. Vaccination history included: Bnt162b2 (DOSE 1, SINGLELOT NUMBER: UNKNOWNADMINISTRATION SITE: ARM LEFT. Administration time=12:45 PM), administration date: 19Apr2021, when the patient was 32 years old, for COVID-19 immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 11May2021 13:00, outcome "not recovered", described as "Muscle at Injection site continue to experience sourness till this day". Therapeutic measures were not taken as a result of vaccination site pain.  Additional information: Prior to the vaccination, the patient was not diagnosed with COVID-19.The patient did not receive any other vaccines within four weeks prior to the vaccination. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
swollen tongue; swollen throat; pain around tongue; pain around neck; Arm pain around injection site; This spontaneous case was reported by an other caregiver and describes the occurrence of SWOLLEN TONGUE (swollen tongue), PHARYNGEAL SWELLING (swollen throat), GLOSSODYNIA (pain around tongue), NECK PAIN (pain around neck) and VACCINATION SITE PAIN (Arm pain around injection site) in a 48-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 28-Mar-2022, the patient experienced SWOLLEN TONGUE (swollen tongue), PHARYNGEAL SWELLING (swollen throat), GLOSSODYNIA (pain around tongue), NECK PAIN (pain around neck) and VACCINATION SITE PAIN (Arm pain around injection site). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, SWOLLEN TONGUE (swollen tongue), PHARYNGEAL SWELLING (swollen throat), GLOSSODYNIA (pain around tongue), NECK PAIN (pain around neck) and VACCINATION SITE PAIN (Arm pain around injection site) had not resolved.        The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.       No concomitant medications were reported. Patient was planning to go to emergency room for check-up for all the events.
This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 17-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
site is red, lil tender but did not hurt; site is red, lil tender but did not hurt; A spontaneous report was received from a consumer concerning a 79-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events site is red, lil tender but did not hurt.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 17 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (batch number: 023M20A) intramuscularly for prophylaxis of COVID-19 infection.  On 25 Feb 2021, the patient experienced the event(s) site is red, lil tender but did not hurt.  Treatment details included None.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), site is red, lil tender but did not hurt was unknown.
erythema & Swelling & pain at (R) arm injection site. Pt admitted on 10-18-2019 & discharged on 10-19-2019 Diag: sterile abscess
the problem is still the same; Wednesday was real bad; I can hardly move, could hardly move the fingers; arm real stiff; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (the problem is still the same), FEELING ABNORMAL (Wednesday was real bad), HYPOKINESIA (I can hardly move, could hardly move the fingers) and MUSCULOSKELETAL STIFFNESS (arm real stiff) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Nov-2021, the patient experienced FEELING ABNORMAL (Wednesday was real bad), HYPOKINESIA (I can hardly move, could hardly move the fingers) and MUSCULOSKELETAL STIFFNESS (arm real stiff). On an unknown date, the patient experienced ADVERSE EVENT (the problem is still the same). At the time of the report, ADVERSE EVENT (the problem is still the same) had not resolved and FEELING ABNORMAL (Wednesday was real bad), HYPOKINESIA (I can hardly move, could hardly move the fingers) and MUSCULOSKELETAL STIFFNESS (arm real stiff) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported that she never received second dose.  No relevant concomitant medications were reported. No treatment information was provided.
Menstruation problems/With the menstruation the problems appeared after 15 day from the second dose; It itches on the body; Like red spots; Swollen/sometimes it goes and sometimes it comes; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUAL DISORDER (Menstruation problems/With the menstruation the problems appeared after 15 day from the second dose), PRURITUS (It itches on the body), RASH PRURITIC (Like red spots) and SWELLING (Swollen/sometimes it goes and sometimes it comes) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In July 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MENSTRUAL DISORDER (Menstruation problems/With the menstruation the problems appeared after 15 day from the second dose), PRURITUS (It itches on the body), RASH PRURITIC (Like red spots) and SWELLING (Swollen/sometimes it goes and sometimes it comes). At the time of the report, MENSTRUAL DISORDER (Menstruation problems/With the menstruation the problems appeared after 15 day from the second dose), PRURITUS (It itches on the body), RASH PRURITIC (Like red spots) and SWELLING (Swollen/sometimes it goes and sometimes it comes) outcome was unknown.            No concomitant medication reported. No treatment medication reported. Reporter stated the village where I live a lot of people is suffering this.
Information has been received from a LPN concerning a patient who was vaccinated with a first dose of varicella virus vaccine live. Four to five days post vax, the patient developed erythema multiforme. Unspecified medical attention was sought and the patient's experience was thought to be an allergy and treated at the time of the occurrence. The patient had a similar experience following exposure to MMR vaccine. Additional information has been requested.
Started with some redness on site the Thursday 12/7/00 got bigger, redness, swollen and itchy. On Friday 12/8/00 worse, red, hot. Mom applied ice but not helpful. Cellulitis tx with Augmentin. Reaction vs cellulitis on arm. Site left deltoid, positive erythema, positive inflammation 7 x 4 cm large.
dull roar in ear, subtle duh duh duh duh; tired; soreness under armpit; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (dull roar in ear, subtle duh duh duh duh), AXILLARY PAIN (soreness under armpit) and FATIGUE (tired) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced AXILLARY PAIN (soreness under armpit). On 24-Mar-2021, the patient experienced TINNITUS (dull roar in ear, subtle duh duh duh duh) and FATIGUE (tired). At the time of the report, TINNITUS (dull roar in ear, subtle duh duh duh duh), AXILLARY PAIN (soreness under armpit) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
pt recvd vax 22OCT93 & w/in 2 hrs devel a red, raised itchy rash from the elbow up to neck; pt subsequently exp localized redness & warmth @ the inject site; pt also had malaise, aching joints, nausea & a h/a;
Information has been received from a pharmacist referring to a 72 year old female patient with asthma. The patient had no drug reactions/allergies. On 21-JUN-2016, the patient was vaccinated with ZOSTAVAX (lot # L035285 with expiry date 30-DEC-2016, 19 400 PFU/single dose), subcutaneously. Concomitant therapies included montelukast 10 mg and unspecified blood pressure medicine. On 23-JUN-2016, the patient experienced chills, itching, a low grade fever, bruising and also about a 1 1/2 inch redness and 1/2 inch swelling at the injection site. BENADRYL was prescribed as the treatment. No lab diagnostics were performed. The patient's present status was reported as recovering. The causality of the events was not reported. Additional information has been requested.
General aches; Headache; Left arm pain at injection site; Left arm pain at injection site; This is a spontaneous report from a contactable other hcp (nurse). A 58-years-old female patient (nurse) received bnt162b2 (BNT162B2, Formulation: Solution for injection), dose 2 intramuscularly administered in Deltoid Left on 20Jan2021 15:40 (Lot Number: EL8982, Expiry date: unknown) as single dose for COVID-19 immunisation. Medical history included hypersensitivity from an unknown date and unknown if ongoing, obesity from an unknown date and unknown if ongoing, diverticulum from an unknown date and unknown if ongoing, gastro oesophageal reflux disease from an unknown date and unknown if ongoing, hypersensitivity from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. There was no family history. The patient previously received first dose (Intramuscularly, LOT number: EL1284, Time: 15:40 hh:mm) of COVID vaccine and experienced Left arm sore, Muscle aches, Chills, Fever 101.2. The patient had all childhood vaccines included MMR in 1980, Tetanus booster in 26Oct2018. Concomitant medication(s) included ketotifen fumarate (KETOTIFEN FUMARATE) 1 gtt each eye QD (Once daily) rare taken for hypersensitivity from an unspecified start date from one year ago and ongoing; famotidine (PEPCID [FAMOTIDINE]) 20mg BID (two times a day) taken for gastro oesophageal reflux disease from an unspecified start date from one year ago and ongoing; pantoprazole sodium sesquihydrate (PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]) 40mg QD (once daily) taken for gastro oesophageal reflux disease from an unspecified start date from one year ago and ongoing; levocetirizine dihydrochloride (XYZAL) 5mg q (Everyday) HS (At bedtime) taken for hypersensitivity from an unspecified start date from one year ago and ongoing; "SENSIMIST FLONASE" 1 puff BID (Two times a day) each taken for oesophageal reflux disease from an unspecified start date from one year ago and ongoing. On 21Jan2021 02:00, the patient experienced general aches, headache, left arm pain at injection site. Side effects occurred day after vaccine and resolved by 2nd day after vaccine. Therapeutic measures were taken with Tylenol and Ice. The outcome of the events were recovered on an unspecified date in Jan2021.
fever; headache; shaking; diarrhea; vomiting; chills; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking), DIARRHOEA (diarrhea), VOMITING (vomiting), CHILLS (chills) and PYREXIA (fever) in a 75-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced TREMOR (shaking), DIARRHOEA (diarrhea), VOMITING (vomiting) and CHILLS (chills). On 10-Feb-2021, the patient experienced PYREXIA (fever) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) on 10-Feb-2021 at an unspecified dose and frequency. On 09-Feb-2021, VOMITING (vomiting) had resolved. On 10-Feb-2021, TREMOR (shaking), DIARRHOEA (diarrhea) and CHILLS (chills) had resolved. On 11-Feb-2021, PYREXIA (fever) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.